In Short:Sun Pharmaceuticals has received a warning letter from the FDA for its Dadra facility due to violations of manufacturing regulations. The contents of...
In Short:Sun Pharmaceutical Industries predicts a high single-digit growth in revenue for the current fiscal year. Managing Director Dilip Shanghvi mentioned that the company...
In Short:Shareholders of Taro Pharmaceutical Industries approved a merger with Sun Pharmaceutical Industries, ending a 10-year feud. Sun Pharma will acquire all Taro shares...
